| scholarly article | Q13442814 |
| P2093 | author name string | D Simon | |
| M Schneider | |||
| D Häussinger | |||
| M Müschen | |||
| U Warskulat | |||
| J Even | |||
| A Perniok | |||
| C Moers | |||
| B Kismet | |||
| N Temizkan | |||
| P2860 | cites work | Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule | Q24305174 |
| Allergic granulomatosis, allergic angiitis, and periarteritis nodosa | Q24682741 | ||
| A naturally occurring soluble isoform of murine Fas generated by alternative splicing | Q28505798 | ||
| T-cell antigen receptor genes and T-cell recognition | Q29619721 | ||
| Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis | Q30080034 | ||
| Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity | Q33488225 | ||
| Fas gene mutations in the Canale-Smith syndrome, an inherited lymphoproliferative disorder associated with autoimmunity | Q33497763 | ||
| The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). | Q34226979 | ||
| Mature T cells of autoimmune lpr/lpr mice have a defect in antigen-stimulated suicide | Q36297378 | ||
| Expansion of cytokine-producing CD4-CD8- T cells associated with abnormal Fas expression and hypereosinophilia. | Q36365810 | ||
| Fas and the art of lymphocyte maintenance | Q36365902 | ||
| Fas ligand is not only expressed in immune privileged human organs but is also coexpressed with Fas in various epithelial tissues | Q37227679 | ||
| Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome. | Q40170990 | ||
| Quantitative titration of nucleic acids by enzymatic amplification reactions run to saturation | Q40405042 | ||
| T-cell repertoire diversity and clonal expansions in normal and clinical samples | Q40515613 | ||
| An experimentally validated panel of subfamily-specific oligonucleotide primers (V alpha 1-w29/V beta 1-w24) for the study of human T cell receptor variable V gene segment usage by polymerase chain reaction | Q44789589 | ||
| Deranged CD95 system in a case of Churg-Strauss vasculitis | Q47998295 | ||
| Monoclonal antibody-mediated tumor regression by induction of apoptosis. | Q55059937 | ||
| Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome | Q55670225 | ||
| The American College of Rheumatology 1990 criteria for the classification of churg-strauss syndrome (allergic granulomatosis and angiitis) | Q56433277 | ||
| Involvement of CD95 (Apo-1/Fas) ligand expressed by rat Kupffer cells in hepatic immunoregulation. | Q64942701 | ||
| Churg-Strauss angiitis. Arguments favoring the responsibility of inhaled antigens | Q68034714 | ||
| Purification of human blood eosinophils by negative selection using immunomagnetic beads | Q69353991 | ||
| Allergic granulomatous vasculitis (Churg-Strauss Syndrome). Report of a case with widespread digestive involvement | Q70792193 | ||
| Induction of apoptosis in human eosinophils by anti-Fas antibody treatment in vitro | Q71704501 | ||
| Regulation of CD95 (APO-1/Fas) receptor and ligand expression by lipopolysaccharide and dexamethasone in parenchymal and nonparenchymal rat liver cells | Q74027176 | ||
| Churg-Strauss syndrome: serum markers of lymphocyte activation and endothelial damage | Q74324029 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 915-925 | |
| P577 | publication date | 1999-09-01 | |
| P1433 | published in | The American Journal of Pathology | Q4744259 |
| P1476 | title | Involvement of soluble CD95 in Churg-Strauss syndrome | |
| P478 | volume | 155 |
| Q27490357 | Anti-Neutrophil Cytoplasmic Antibody Pathogenesis in Small-Vessel Vasculitis |
| Q73395786 | CD95 ligand expression as a mechanism of immune escape in breast cancer |
| Q73029473 | Churg-Strauss syndrome |
| Q84043490 | Churg-Strauss syndrome |
| Q40617823 | Churg-strauss syndrome in the pediatric age group |
| Q37850388 | Cutting edge issues in the Churg-Strauss syndrome |
| Q50903151 | Decreases in the numbers of peripheral blood regulatory T cells, and increases in the levels of memory and activated B cells, in patients with active eosinophilic granulomatosis and polyangiitis. |
| Q40545622 | Dendritic cells overexpressing Fas-ligand induce pulmonary vasculitis in mice. |
| Q39872550 | Diagnostic and therapeutic management of Churg-Strauss syndrome |
| Q40232926 | Discoidin domain receptor 1 contributes to eosinophil survival in an NF-kappaB-dependent manner in Churg-Strauss syndrome |
| Q40823074 | Elevated interleukin-4 and interleukin-13 production by T cell lines from patients with Churg-Strauss syndrome |
| Q38075024 | Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): state of the art. |
| Q36847447 | Eosinophils in vasculitis: characteristics and roles in pathogenesis |
| Q46795578 | Hypereosinophilic syndrome and Churg-Strauss syndrome: is it clinically relevant to differentiate these syndromes? |
| Q56745222 | Increased expression of TRAIL receptor 3 on eosinophils in Churg-Strauss syndrome |
| Q36183288 | Off balance: T-cells in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides |
| Q34109103 | Perspective on future therapy of vasculitis |
| Q36242795 | Proinflammatory cytokines and autoimmunity in Churg-Strauss syndrome |
| Q38206113 | Pulmonary vasculature and critical asthma syndromes: a comprehensive review |
| Q37690935 | Rituximab in the treatment of refractory or relapsing eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome). |
| Q81639986 | [Churg-Strauss syndrome--case report] |
| Q85397954 | [Update Churg-Strauss syndrome] |
Search more.